PubHealth.info® (An Information Portal on Public Health Issues / Topics, Presented in Collaboration with PakMed Biomedical Solutions)

[PubHealth.info Homepage] [Category Homepage] [Disclaimer/Copyrights] [Feedback]


Thank you for your kind visit to PubHealth.info®, an information portal created in technical collaboration with PakMed Biomedical Solutions * * * PubHealth.info® presents hundreds of thousands of informative Web pages on a variety of public health issues / issues * * * An ultimate source of information for teachers, students and research workers who need to find information on various public health issues, like population planning, contraception, HIV AIDS, STDs, maternal and child health, communicable and non-communicable disease, etc. * * * PubHealth.info® regularly updates the repository of these hundreds of thousands of informative Web pages * * * PubHealth.info® is one of the world's largest repositories and information portals with online Web pages on public health issues particularly those pertaining to developing countries!

PubHealth.info® (a subsidiary of PakMed) presents scientific information mainly based on abstracts of articles published on a variety of public health issues/topics, particularly encompassing population planning, disease prevention, maternal and child health, and communicable and non-communicable diseases (like HIV AIDS, malaria, etc) that are affecting a significant portion of population in developing and developed countries. Here you can find abstracts of articles published on a variety of public health topics under category "Contraception (Birth Control) and Family Planning". Contraception (birth control) is a regimen of one or more actions, devices, or medications followed in order to deliberately prevent or reduce the likelihood of a woman becoming pregnant or giving birth. Therefore contraception is the utilization of various and sundry surgical procedures, devices, practices, agents, or drugs with the intention of preventing conception or impregnation (pregnancy). Methods and intentions typically termed birth control may be considered a pivotal ingredient to family planning. Birth control is a controversial political and ethical issue in many cultures and religions, and although it is generally less controversial than abortion specifically.

Here you can find more than 42,000 article titles on "Contraception (Birth Control) and Family Planning" , along with their abstracts and bibliographic information (one of the world's largest collections of article titles on this topic), mentioned in various lists that are sorted/arranged according to the years of publication. You can view the bibliographic details and abstracts of these articles, by clicking the title of your required article. To view other lists of articles in the same category "Contraception (Birth Control) and Family Planning", please visit "Category Lists Homepage" or select a list from the following dropdown list of article titles.

 

List 30: Articles 14501-15000 (500 Articles)

To view other lists in the same category, please VISIT LISTS HOME PAGE or select a list from the above dropdown list of article titles
  1. Contraceptive usage.
  2. Contraceptive use and controlled fertility: health issues for women and children; background papers.
  3. Contraceptive use and fertility decline in Chogoria, Kenya.
  4. Contraceptive use and sexual practice among young people in Sao Paulo. [Uso de anticonceptivos e pratica sexual do jovem na cidade de Sao Paulo.]
  5. Contraceptive use in China.
  6. Contraceptive users' sources of supply.
  7. Contraceptive utilization in and out of the marital setting: implications for the transmission of HIV in Kinshasa.
  8. Contraceptives in high risk reproduction: a health goal still far away. Editorial. [La anticoncepcion en el alto riesgo reproductivo, una meta de salud todavia lejana.]
  9. Contraceptives, their health benefits and hazards.
  10. Contraceptives: a look at the future.
  11. Contraceptives: final report on a qualitative research study among males and females.
  12. Control of the pill evaluated at its true value: standard oral contraception (letter) [De pilcontrole op waarde geschat; de standaard "orale anticonceptie".]
  13. Correlates and determinants of contraceptive method choice in Indonesia.
  14. Correlates and determinants of women's participation in decision-making about family planning in Egypt.
  15. Correlates of continuity in contraceptive use: a review of research needs.
  16. The correlation between family planning program inputs and contraceptive use in Indonesia.
  17. Correlation of contraceptive activity of norethisterone and levonorgestrel esters with VR(w) values and hydrolysis rates.
  18. The cost and cost-effectiveness of the Matlab family planning health services project.
  19. Cost-effectiveness analysis: natural family planning and breastfeeding programs.
  20. Counselling women with HIV infection about pregnancy, heterosexual transmission and contraception.
  21. Creative approaches to encourage male responsibility and involvement in family planning.
  22. The current and future contraceptive needs of Japanese women.
  23. Current state of family planning in Japan.
  24. Current status of and prospects for contraception. [Attualita e prospettive in tema di contraccezione.]
  25. The current status of oral contraceptive clinical development in Japan.
  26. Cytopathological changes in human cervix and endometrium following prolonged retention of copper-bearing intrauterine contraceptive devices.
  27. Danazol: an alternative in postcoital contraception. [Danazolo: un'alternativa nell'intercezione post-coitale.]
  28. A decade of Nepal's family planning program: achievements and prospects.
  29. Decision No. 162 Concerning a Number of Population and Family Planning Policies.
  30. Delivery of Family Planning and Health Services in Campesino and Indigenous Communities in Ecuador, Contract No. CI86.06A, April 1, 1986 - July 31, 1989. Final report.
  31. The demand for family planning: estimates for developing countries.
  32. Demographic and family planning situation in Peru. [Situacion demografica y planificacion familiar en el Peru.]
  33. Demographic and programmatic consequences of contraceptive innovations.
  34. Demographic aspects of natural family planning.
  35. Demographic growth and family planning: situation in Colombia. [Crecimiento demografico y planificacion familiar: situacion en Colombia.]
  36. Demographic growth and family planning: situation in Mexico. [Crecimiento demografico y planificacion familiar: situacion en Mexico.]
  37. The demographic impact of changes in contraceptive practice in Third World populations.
  38. The demographic impact of changes in contraceptive practice in Third World populations.
  39. Demographic knowledge and family planning in Colombia. [Crecimiento demografico y planificacion familiar situacion en Colombia.]
  40. Designing a national family planning logo: the Nigeria experience.
  41. Determinants and consequences of contraceptive method choice in India.
  42. Determinants of fertility in Egypt using the Follow Up Survey of Family Life and Family Planning (1981 - 1982)
  43. Developing a fee-charging contraceptive distribution system in Indonesia: the experience of Kusuma Buana Foundation.
  44. Developing a `well woman' service staffed by family planning-trained clerks, nurses and doctors.
  45. Developing company-based family planning services: a module for use by trainers in workshops for managers. Draft.
  46. Developing health and family planning print materials for low-literate audiences: a guide.
  47. Development of a multidimensional contraceptive attributes questionnaire.
  48. Developments in family planning policies and programmes in Africa. Proceedings of the Colloquium on the Impact of Family Planning Programmes in Sub-Saharan Africa: current issues and prospects.
  49. The dexamethasone suppression test and long-term contraceptive treatment: measurement of ACTH or salivary cortisol does not improve the reliability of the test.
  50. The differential effects and considerations of family planning programs in basic units.
  51. The diffusion of modern contraception in Norway and its consequences for the fertility pattern.
  52. Directory of training courses in family planning and maternal and child health, 1988-89 edition.
  53. Distribution of contraceptives. Relation between exposure time and degree of efficacy. Second report. [Distribucion de los metodos anticonceptivos. Relacionados con su tiempo de exposicion y el grado de eficacia. Segundo informe.]
  54. Diversity in family planning provision and practice.
  55. Domiciliary family planning services.
  56. Dominican Republic. Demand and supply of family planning. Technical summary. [Republica Dominicana: demanda y oferta de planificacion familiar. Resumen tecnico.]
  57. Doxylamine and diphenhydramine pharmacokinetics in women on low-dose estrogen oral contraceptives.
  58. Duration of contraception after etretinate [letter]
  59. Dynamics of contraceptive use.
  60. The dynamics of contraceptive use: an overview.
  61. The dynamics of traditional contraceptive use: the role of fertility awareness and coital behavior.
  62. Early oral contraceptive use and breast cancer among premenopausal women: final report from a study in southern Sweden.
  63. An economic analysis of the determinants of contraceptive use in Matlab, Bangladesh.
  64. Economic constraints in family planning and contraceptive use in Africa.
  65. The economics of private sector family planning service provision in Indonesia.
  66. Ectopic pregnancy associated with intrauterine contraception. [Ektope Graviditat bei intrauteriner Kontrazeption.]
  67. Editorial comment: kudos to the Food and Drug Administration: reversal of the package insert warning for birth defects for oral contraceptives.
  68. Education and prevalence of contraception in West Bengal and Bihar.
  69. Education attainment, modernization and fertility reduction--analysis of the family planning policy of India.
  70. Educational communication in reproductive health and family planning. The experience of the Instituto Mexicano del Seguro Social. [Comunicacion educativa en salud reproductiva y planificacion familiar. La experiencia del Instituto Mexicano del Seguro Social.]
  71. Educational information on family planning, sex education and related subjects for a telephone "hot line". [Informacoes educativas sobre planejamento familiar, orientacao sexual e temas correlatos por telefone-"hot line".]
  72. Effect of a combined oral contraceptive [Planum] on the breast, studied by thermo-echo-clinical examination. [L'influenza sulla mammella di un contraccettivo orale di tipo combinato (Planum), indagata con l'esame termo-eco-clinico.]
  73. Effect of an oral contraceptive in primary dysmenorrhea --changes in uterine activity and reactivity to agonists.
  74. The effect of antibiotics on the efficacy of oral contraceptives: a controversy revisited.
  75. The effect of contraceptive prices on method choice in the Philippines, Jamaica, and Thailand.
  76. Effect of copper-containing intrauterine contraceptive devices (IUCD) on growth of endometrial and cervical cells.
  77. Effect of disease and drug interactions on the response to oral contraceptive steroids.
  78. The effect of lipopolysaccharides (LPS) on generation of thromboxane A2 and thromboplastin activity in whole blood of males, females and females on oral contraceptives.
  79. Effect of low-dose oral contraceptives on natural killer cell activity.
  80. The effect of oral contraceptives on the intraindividual variation of clinico-biochemical parameters. [Einfluss oraler Kontrazeptiva auf die intraindividuelle Variation klinisch-biochemischer Parameter.]
  81. The effect of sexual behavior and a pregnancy on contraceptive method switching among black female teens.
  82. Effect of some oral contraceptives on serum concentrations of sex hormone binding globulin and ceruloplasmin.
  83. Effect of son preference on subsequent fertility and family planning -- a global and Indian experience.
  84. The effect of the intrauterine contraceptive device on endometrial secretory function: a possible mode of action.
  85. The effectiveness of family-planning programmes.
  86. Effects of demographic factors on the use and effectiveness of new contraceptive technologies.
  87. The effects of mass media and community organizations on the adoption of the family planning program in Jakarta, Indonesia.
  88. Effects of new contraceptive methods on abortion utilization.
  89. Effects of oral contraceptive and estrogen administration on plasma calcitonin in pre- and postmenopausal women.
  90. The effects of oral contraceptives and parity on ovarian cancer trends in women under 55 years of age.
  91. Effects of oral contraceptives on circulating lipids and lipoproteins: maximizing benefit, minimizing risk.
  92. The effects of two triphasic oral contraceptives on carbohydrate metabolism in women during 1 year of use.
  93. Effects on progeny of exposure to hormonal contraceptives in utero or through breast milk.
  94. Efficacy and effectiveness of temporary contraceptive methods of the family planning service of MEAC, 1988. [Eficacia e para-efeitos dos metodos anticonceptivos provisorios do servico de planejamento familiar da MEAC - 1988.]
  95. Efficacy of barrier methods in contraception.
  96. Effort thrombosis of the axillary and subclavian vein associated with cervical rib and oral contraceptives in a young woman athlete.
  97. Emerging concepts towards the development of contraceptive agents.
  98. Enhancing contraceptive acceptance through local Mahila Mandals: one experience in rural Haryana.
  99. Epidemiologic assessment of effects of steroidal contraceptives on the liver and gallbladder.
  100. Epidemiological assessment of cardiovascular effects of hormonal contraception.
  101. The epidemiological assessment of the safety of hormonal contraceptives: a methodological review.
  102. Epidemiological studies of oral contraception.
  103. Erotophobia and contraception among Zimbabwean students.
  104. The establishment of parity-variable fertility model based on family planning practice.
  105. Estimates of the total fertility rates (TFR) of some selected areas of Egypt based on the Egypt Contraceptive Prevalence Survey (ECPS, 1984)
  106. Estimating the potential demand for family planning in sub-Saharan Africa.
  107. Ethical approaches to family planning in Africa.
  108. Ethics and human values in family planning [editorial]
  109. Ethics and human values in family planning, conference highlights, papers and discussion, XXII CIOMS Conference, Bangkok, Thailand 19-24 June 1988.
  110. Ethics and human values in family planning: a Latin American experience.
  111. Ethics and human values in family planning: Africa regional perspective.
  112. Ethics and human values in family planning: European and North American perspectives.
  113. Ethics and human values in family planning: legal and legislative aspects.
  114. Ethics and human values in family planning: perspectives of Asia and Oceania.
  115. Ethics and human values in family planning: perspectives of different cultural and religious settings.
  116. Ethics and human values in family planning: perspectives of the Middle East.
  117. Ethics and human values in family planning: scientific and health aspects.
  118. Evaluation as the administrative arm of family planning. [La evaluacion como arma administrativa en planificacion familiar.]
  119. Evaluation of family planning and MCH programme in Ahmedabad district of Gujarat.
  120. Evaluation of the Bangladesh Upazila Initiative Subproject of the Family Planning and Health Services Project.
  121. Evaluation of the determinants of contraceptive prevalence and total fertility rates in Indonesia.
  122. An evaluation of the Family Planning Association of Kenya Community Based Distribution Pilot Project, 1989. Background materials and detailed reports, Vol. II.
  123. An evaluation of the Family Planning Association of Kenya Community Based Distribution Pilot Project, 1989. Major findings and selected recommendations, vol. I.
  124. Evaluation of the knowledge, attitudes and advocacy of providers of family planning services in Lusaka.
  125. Evaluation of the Pakistan Social Marketing of Contraceptives Project (391-0484)
  126. Evaluation of the training of health promoters in family planning. [Evaluacion de la capacitacion de promotoras de salud en planificacion familiar.]
  127. Evaluation of the USAID/NEPAL Integrated Rural Health / Family Planning Services Project, No. 367-0135.
  128. Evaluation of training program for volunteer family planning communicators.
  129. Evaluation of urban component of Family Planning Development and Services II. Project 497-0327.
  130. Evaluation report: CAFS Family Planning Training Support Project for Francophone Africa.
  131. Evaluation report: JHPIEGO Regional Family Planning Training Support Project for Francophone Africa.
  132. Evidence that contraceptives such as OCs affect HIV transmission.
  133. Evolution and growth of family planning in Zimbabwe.
  134. The evolution and impact of policies on fertility and family planning: Brazil, Colombia, and Mexico.
  135. Evolution and status of family planning in Nigeria.
  136. An examination of young adolescents' knowledge of and attitude toward sexuality according to perceived contraceptive responsibility.
  137. Expanded nursing care for contraceptive use.
  138. Expanding contraceptive options.
  139. Expert group reviews implications of reversal for family planning programs.
  140. Extending family planning services through Third World women managers: an interim evaluation of the CEDPA Population Project.
  141. Falling fertility in Indonesia: success in national family planning.
  142. The family center--a new form of organization for rural family planning.
  143. Family planning -- a cornerstone of Chinese politics. [Familjeplanering -- en hornsten i kinesisk politik.]
  144. Family planning against the odds.
  145. Family planning among the Kols of Manikpur block (U.P.)
  146. Family planning and AIDS prevention: technical and managerial guidelines. Draft.
  147. Family planning and development helping women world-wide.
  148. Family planning and fertility control in India.
  149. Family planning and fertility in international context.
  150. Family planning and gender issues in Kenya.
  151. Family planning and infant and child survival.
  152. Family planning and management interventions : a case study of Uttar Pradesh.
  153. Family planning and married fulfillment.
  154. Family planning and maternal and child health: the experience in Ghana.
  155. Family planning and population aging in China.
  156. Family planning and population control: the challenges of a successful movement.
  157. Family planning and related services.
  158. Family planning and sex education. [Planificacion familiar y educacion sexual.]
  159. Family planning and the law.
  160. Family planning and the National Health Service.
  161. Family planning and vocations.
  162. Family Planning Association of Kenya contraceptive booklet evaluation project (in conjunction with PIACT / PATH). Part I: Findings and analysis.
  163. Family planning at the community level. A message from African women.
  164. Family planning attitudes and behaviors in urban Niger, West Africa.
  165. Family planning attitudes and consumer behavior. Turkish focus groups. Draft.
  166. Family planning by aliens. [Gezinsplanning bij allochtonen.]
  167. The family planning campaign and other IE and C activities in Turkey.
  168. The family planning campaign and other IE&C activities in Turkey.
  169. Family planning comes of age in Niger. A post-project survey of family planning knowledge, attitudes, and practice in Niamey, Maradi, and Zinder, October 1989.
  170. Family planning communication and pill promotional programme management.
  171. Family planning communication between spouses in Sri Lanka.
  172. Family planning communication program monitoring and evaluation in Ghana.
  173. Family planning costs and benefits.
  174. Family planning counseling after extrauterine pregnancy. [Csaladtervezesi tanacsadas mehenkivuli terhesseget kovetoen.]
  175. Family Planning Demands.
  176. Family planning during breast feeding. [Planificacion familiar durante el periodo de lactancia.]
  177. Family planning evaluation--data, methods and research issues with special reference to Africa.
  178. Family planning in Africa: the relevance of gender issues.
  179. Family planning in an at-risk group: adolescents and young people (letter) [Planificacion familiar en un grupo de riesgo: adolescentes y jovenes.]
  180. Family planning in five continents.
  181. Family planning in Flanders. Results of the Fourth Survey on Family Development (NEGO IV, 1982-83) [Gezinsplanning in Vlaanderen. Resultaten van de vierde C.B.G.S.-survey over gezinsontwikkeling (NEGO IV, 1982-1983)]
  182. Family planning in Indonesia: new paths for development.
  183. Family planning in primary care: one year experience in a health center. [Planificacion familiar en atencion primaria. Un ano de experiencia en un centro de salud.]
  184. Family planning in the Sudan: a pilot project success story.
  185. Family planning in the USSR: the main medico-demographic features. [Planirovanie semi v SSSR. Osnovnye mediko-demograficheskie kharakteristiki.]
  186. The family planning law should be issued as soon as possible.

     

  187. The Family Planning Management Training Project external interim evaluation.
  188. Family planning market survey.
  189. Family planning needs in teacher training colleges in Kenya.
  190. Family Planning Operations Research / Asia Project. Progress report, September 1, 1988 - February 28, 1989.
  191. Family planning policy's impact on abortion practices in Kenya.
  192. Family planning practices among tribals: a study of indigenous and modern contraception in tribals of South Rajasthan.
  193. Family planning program effort and the initiation of contraceptive use: a multi-level analysis.
  194. The family planning programme in Jordan.
  195. The family planning programme in Pakistan.
  196. Family planning programs and contraceptive practice in Khao I Dang and Ban Vinai refugee camps: results of the 1988 survey.
  197. Family planning promotes safe motherhood.
  198. Family Planning Regulations, 21 July 1989.
  199. Family Planning Regulations, October 1989.
  200. Family planning successes applied to AIDS prevention. [Exitos de la planification familiar en la prevencion del SIDA.]
  201. Family planning training program [years 1985-1988, N'Djamena, Chad. [Formation en planification familiale, annee 1985-1988, N'Djamena, Tchad.]
  202. Family planning trends in a Reading hospital.
  203. Family planning, population policy and declining birth rates in Yugoslavia.
  204. Family planning--through the looking glass.
  205. Family planning: an integral part of primary health care.
  206. Family relationships and the politics of family planning in black francophone Africa: problems and practices. [Relations familiales et politiques de planning familial en Afrique noire francophone: droit et practiques.]
  207. Family sex composition preferences and contraceptive use in Thailand: a relative risk analysis.
  208. Family-planning clinics and educational programmes -- a rural experience.
  209. Farmers and family planning.
  210. Federal Republic of Germany: family planning, family policy and demographic policy.
  211. Female adolescents' compliance with contraceptive regimens.
  212. Female contraceptive vaccine possible, but not for years.
  213. Female surgical contraception in Kenya-- the Kenyatta National Hospital experience.
  214. Fertility and family planning (an annotated bibliography) [Fecundidad y planificacion familiar (bibliografia anotada)]
  215. Fertility and family planning in Northern Ireland.
  216. Fertility and family planning in Thailand, 1987.
  217. Fertility reduction and the quality of family planning services.
  218. Fertility, menstrual characteristics, and contraceptive practices among white, black, and southeast Asian refugee adolescents.
  219. Fertility, mortality and contraceptive prevalence in a tribal population.
  220. Final evaluation of the TFHPF's family planning IEC campaign of 1988-89. Draft.
  221. Final report of community based family planning promotion and service delivery study in Ruhengeri, Rwanda. [Rapport de l'etude sur la promotion et la prestation des services de planification familiale a base communautaire a Ruhengeri Rwanda.]
  222. Final report of the workshop on management and training for community-based family planning and primary health care in Africa, [sponsored by] Department of Obstetrics and Gynaecology, College of Medicine, University of Ibadan, Oyo State Ministry of Health, and Center for Population and Family Health, Columbia University School of Public Health, March 6th through 31st, 1989, Ibadan, Nigeria.
  223. Final report: "Client-Designed Family Planning Service Delivery Systems: an Attempt to Provide Culturally Acceptable Services for the Indigenous Population in Guatemala", AGES (Asociacion Guatemalteca de Educacion Sexual), Contract No. CI88.15A, March 1, 1988 - July 31, 1989.
  224. Final report: "Evaluation of the Impact of Rezoning on Three Family Planning Agencies in Lima, Peru", INPPARES (Instituto Peruano de Paternidad Responsable), PROFAMILIA (Promocion de Labores Educativas y Asistenciales en Favor de la Salud), APROSAMI (Asociacion de Profesionales en Salud Materno-Infantil). Contract Nos. CI87.70A, CI87.71A/CI89.25A and CI87.72A, November 15, 1987 - May 31, 1989.
  225. Final report: "IEC Service Delivery and Condom Distribution through Family Planning Organizations for AIDS and STD Prevention", PROFAMILIA (Asociacion Pro-Bienestar de la Familia Colombiana). Contract No. CI88.04A, January 1, 1988 - July 31, 1989.
  226. Final report: "Involving Family Planning Workers in an AIDS Prevention Campaign in Lima, Peru", Asociacion Benefica PRISMA (Proyectos en Informatica, Salud, Medicina y Agricultura), Ministry of Health, Peru. Contract No. CI87.77A/CI88.36A, November 20, 1987 - September 15, 1989.
  227. Final report: INOPAL Operations Research Project. Operations Research to Improve Ministry of Health Family Planning Services in the Departments of Ayacucho and Huancavelica, Peru, (Population Council sub-grant CI87.08A)
  228. Final report: Needs Assessment for Training of Oral Contraceptive Use for Drug Store Personnel in Thailand.
  229. Final report: Primary Prevention Trial of Barrier Contraceptives against HTLV-III Infection. Contract NO1-HD-62934. Executive summary.
  230. Final report: retail audit (full nationwide product launch) conducted for Famcare Inc., the Liberia Contraceptive Social Marketing Program.
  231. Final technical report. Reproductive Risk: a Strategy to Improve Family Planning Service in the Honduran Social Security Institute, Contract CI88.41A.
  232. Final Technical Report: "Family Planning Based on Reproductive Risk", Instituto Mexicano del Seguro Social, Academia Mexicana de Investigacion en Demografia Medica, A.C. (AMIDEM), Contract CI86.18A, July 1, 1986 - May 31, 1989.
  233. Financing the delivery of contraceptives: the challenge of the next twenty years.
  234. First quarterly report (January - March 1989). Social Marketing of Contraceptives Project, Pakistan.
  235. Fiscal 1989 international programs: workplan of the Association for Voluntary Surgical Contraception.
  236. Focus group research to determine family planning training and IEC needs.
  237. Folic acid deficiency, megaloblastic anemia and peripheral polyneuropathy due to oral contraceptives.
  238. A framework for management development of family planning program managers.
  239. Freedom of choice or fertility control: 500 bibliographic references on family planning in Mexico, 1968-1982. [Libre eleccion o fecundidad controlada: 500 referencias bibliograficas sobre la planificacion familiar en Mexico, 1968-1982.]
  240. From community distribution to community marketing of contraceptives: themes for thought. [De la distribucion comunitaria al mercadeo comunitario de anticonceptivos - temas de reflexion.]
  241. Future developments and availability of new contraceptive technologies with special reference to India.
  242. The future of birth control. Our present methods are outdated -- and unless we act now, they'll never be better.
  243. Gambia Family Planning Association male involvement project with the Gambia gendarmerie.
  244. Gandhi addresses the world on family planning.
  245. Ghana National Family Planning Programme.
  246. Global contraceptive use rises.
  247. Glossary of natural family planning terms. [Glosario de terminos utilizados en la planificacion familiar natural.]
  248. Glossary of natural family planning. [Glossaire sur la planification familiale naturelle.]
  249. Glucose and insulin levels after six months of treatment with a triphasic oral contraceptive containing ethinyl estradiol and norethindrone.
  250. Grasp the work of family planning by unifying thinking and stabilizing the policy.
  251. Gross pelvic adhesions associated with a fimbrial cap contraceptive.
  252. Guide to effective counseling about Norplant, contraceptive subdermal implants developed by the Population Council.
  253. Guide to effective counseling about Norplant, contraceptive subdermal implants.
  254. Guide to family planning and reproductive health care.
  255. Guidelines and requirements for the evaluation of contraceptive steroids.
  256. Handbook of contraception and abortion.
  257. Hans Lehfeldt, pioneer of family planning in Europe and America. [Hans Lehfeldt -- Pionier der Familienplanung in Europa und Amerika.]
  258. Harare Conference on Management of Family Planning Programmes, Harare, Zimbabwe, 1-7 October 1989. Summary of conference proceedings and recommendations.
  259. Health effects of contraception.
  260. The health effects of oral contraceptives: misperceptions, controversies, and continuing good news.
  261. Health risks of intrauterine contraception. [Zdravstveni rizici intrauterine kontracepcije.]
  262. Hemichorea induced by oral contraceptive use [letter]
  263. Heparin cofactor II activity in plasma during pregnancy and oral contraceptive use.
  264. Hepatic adenoma and oral contraceptive use.
  265. Herpes gestationis acquired during oral contraceptive use. [Herpes gestationis bei Einnahme eines oralen Kontrazeptivums.]
  266. Histologic effects of oral contraceptives on the uterine corpus and cervix.
  267. Histologic types of breast carcinoma in relation to international variation and breast cancer risk factors. WHO Collaborative Study of Neoplasia and Steroid Contraceptives.
  268. Histopathology of breast cancer in young women in relation to use of oral contraceptives.
  269. Historical perspectives on the introduction of contraceptive technology.
  270. The history of contraceptives.
  271. Hormonal contraception and trophoblastic sequelae after hydatidiform mole (a Gynecologic Oncology Group study)
  272. Hormonal contraception in 46 public family clinics in Rome. [Indagine sulla contraccezione ormonale in 46 consultori familiari pubblici di Roma.]
  273. Hormonal contraception in the male. [Hormonale Kontrazeption beim Mann.]
  274. Hormonal contraception.
  275. Hormonal contraceptives and breast cancer. [Hormonale Kontrazeptiva und Mammakarzinom.]
  276. Hormonal contraceptives and risk of cervical cancer.
  277. Hormonal contraceptives, human papillomaviruses and cervical cancer; some observations from a colposcopy clinic.
  278. Hormonal contraceptives. Uses -- risks. [Hormonale Kontrazeptiva. Nutzen -- Risiko.]
  279. Household Survey of Family Planning Knowledge, Attitudes and Practices: Niamey -- Maradi -- Zinder, 1989.
  280. How family planning organizations can help prevent AIDS in Colombia.
  281. How natural is "natural family planning"? Critical remarks from the biological behavior viewpoint (editorial) [Wie naturlich ist die "naturliche Familien-Planung"? Kritische Anmerkungen aus verhaltensbiologischer Sicht.]
  282. Human development and family planning choices.
  283. Human papillomavirus in cervical smears taken from women wearing an intrauterine contraceptive device.
  284. The human right to family planning.
  285. Hybrid coconut seedlings, scholarships, and discount cards for family planning acceptors.
  286. Hypercarotenemia associated with an oral contraceptive [letter]
  287. Idiopathic thromboembolism associated with triphasic oral contraceptives.
  288. An illustration of survival analysis: factors affecting contraceptive discontinuation among American teenagers.
  289. Immunological birth control. [Immunologische Geburtenkontrolle.]
  290. The impact of contraception and induced abortion on fertility in India.
  291. The impact of family planning on fertility in China: an evaluation.
  292. The impact of maternal and child health and family planning (MCH/FP) programmes on fertility, infant and childhood mortality and maternal health.
  293. An implantable contraceptive: Norplant. [Un contraceptif implantable: le Norplant.]
  294. Implementing a counseling training program to enhance quality of care in family planning programs in Ecuador.
  295. The importance of contraceptive attributes among college students.
  296. The importance of the worldwide contraceptive experience to Japanese physicians.
  297. Improving access to family planning services in Cite Soleil, Haiti, final report.
  298. Improving family planning services to rural adolescents.
  299. Improving family planning, health, and nutrition in India: experience from some World Bank-assisted programs.
  300. Improving productivity levels: family planning services for factory workers.
  301. Improving the climate of choice: the effect of organizational change on contraceptive behavior in rural Bangladesh.
  302. Inadvertent pregnancies in oral contraceptive users.
  303. Income-generating activities for family planning acceptors.
  304. Increasing contraceptive prevalence in Lakshmipur district: final report.
  305. Increasing contraceptive use in Bangladesh: the role of demand and supply factors.
  306. India's family planning programme: emerging issues.
  307. India. Knowledge and attitudes of grassroots family planning workers about contraceptive methods.
  308. Indonesia facts. Backgrounder: family planning in Indonesia.
  309. Indonesia moves towards private family planning.
  310. Indonesia's family planning program works toward self-sufficiency.
  311. The Indonesian family planning program through charts and pictures, 1988/1989.
  312. Infection control in family planning facilities.
  313. Infertility and family planning [editorial]
  314. The influence of contraception on couple method preference. [Influencia de la anticoncepcion en los estilos y modelos de pareja.]
  315. The influence of oral contraceptives and habitual physical activity on serum lipids in black adolescents and young women.
  316. The influence of pregnancy and contraceptive steroids on the biliary tract and its reference to cholesterol gallstone formation.
  317. Influences on previous contraceptive use / non-use in pregnant 16-19 year olds.
  318. Initial survey on family planning knowledge, attitudes, and practice (KAP) in two provinces of Burkina Faso, Kenedougou and Zoundweogo, Burkina Faso, March-May 1989. [Enquete initiale sur les connaissances, les attitudes et les pratiques liees a la planification familiale dans deux provinces du Burkina Faso, Kenedougou et Zoundweogo, Burkina Faso, Mars-Mai 1989.]
  319. Injectable contraception.
  320. Institutional constraints on the provision of family planning services in Latin America.
  321. Institutional constraints to family planning in the Arab east.
  322. Integrating AIDS prevention activities into family planning association programs in Latin America and the Caribbean.
  323. Let's make family planning a household word.
  324. Levels and trends of contraceptive use as assessed in 1988.
  325. Levels of Protein S during the normal menstrual cycle and in women on oral contraceptives low in estrogen.
  326. Linkages between the demand for children, contraceptive use, and fertility: preliminary evidence from Mexico and unresolved issues.
  327. Liver adenoma and oral contraception. Clinical and therapeutic aspects. Report of a case of giant adenoma. [Adenomes du foie et contraception orale. Aspects cliniques et therapeutiques a propos d'un adenome geant.]
  328. Locus-of-control, knowledge and use of contraceptives among black adolescent females.
  329. Long-term oral contraceptive use does not affect trabecular bone density.
  330. Longterm follow up of women treated with Norplant levonorgestrel contraceptive implants. [Seguimiento a largo plazo de mujeres tratadas con implantes anticonceptivos de levonorgestrel Norplant.]
  331. Low-dose monophasic and multiphasic oral contraceptives: a review of potency, efficacy, and side effects.
  332. Low-dose oral contraceptives and cardiovascular disease.
  333. Magnetic resonance imaging of cerebral venous thrombosis secondary to "low-dose" birth control pills.
  334. Making family planning services HIV aware. A training pack for HIV prevention.
  335. Making family planning services more accessible and affordable in the 1990's.
  336. Making family planning work: a policymaker's checklist.
  337. Male attitudes towards family planning, a study of St. Lucian men.
  338. Male farmers as family planning motivators: a new strategy for the Philippines.
  339. Male involvement in planned parenthood: global review and strategies for programme development.
  340. Management of a unique logistic system for the private family planning institutions in Peru. [Manejo de un sistema logistico unico para la instituciones privadas de planificacion familiar en el Peru.]
  341. Management of family planning motivation programmes in Ghana.
  342. Management of genital tract infections of the clients of family planning services. [Prise en charge des infections du tractus genital (ITG) de la clientele des services de planification familiale.]
  343. Management process of a contraceptive method: the choice of a method. [Processus de gestion d'une methode contraceptive: le choix d'une methode.]
  344. Management strategies for family planning programs.
  345. Manual for community distribution of contraceptives. [Manual de la distribuidora comunitaria de anticonceptivos.]
  346. Many children mean many worries. Family planning IEC program. Focus group interviews with Burkina Faso villagers. [Beaucoup d'enfants signifie beaucoup de soucis: programme IEC sur la planification familiale: interviews de groupes dirigees avec des villageois du Burkina Faso.]
  347. Marriage age, family size motivations and contraceptive prevalence in Uttar Pradesh.
  348. Mary wants only six children. Family planning in Malawi.
  349. Maternal and child health and family planning programmes [sectoral paper]
  350. Maternal use of oral contraceptives and Down syndrome.
  351. Measuring components of family planning program effort.
  352. Measuring the quality and duration of contraceptive use: an overview of new approaches.
  353. Men and family planning in Kenya: an exploration.
  354. Men and family planning in the Caribbean, a select bibliography.
  355. Mercilon -- a new low-dose combined oral contraceptive.
  356. Metabolic and cardiovascular aspects of oral contraceptives.
  357. Metabolic aspects of the new low-dose oral contraceptives.
  358. Metabolic effects of contraceptive steroids.
  359. Metabolic effects of low-dose fluconazole in healthy female users and non-users of oral contraceptives.
  360. Metabolism of the contraceptive steroid desogestrel by the intestinal mucosa.
  361. Methodologies for evaluating the impact of contraceptive social marketing programs.
  362. Methodologies for evaluating the impact of contraceptive social marketing programs.
  363. Methods for measuring the fertility impact of family planning programs: the experience of the last decade.
  364. The Mexican family planning programme.
  365. Mexico: adolescent contraceptive behavior and public policy.
  366. Microbiology in family planning.
  367. Microcapillary angiomas, observations in pregnant women and those taking oral contraceptives. [Zur Kenntnis mikrokapillarer Angiome, Beobachtungen bei schwangeren bzw. unter hormoneller Antikonzeption stehenden Frauen.]
  368. Midterm evaluation of Family Planning Development and Services II Project Voluntary Sterilization Component, A.I.D. Project No. 497-0327 (G)
  369. Midterm evaluation of Family Planning Logistics Management Project.
  370. Midterm evaluation of the Contraceptive Research and Development (CONRAD) Program.
  371. Midterm evaluation of Tunisia Family Planning and Population Development Project (664-0331)
  372. Midterm evaluation: Ghana Contraceptive Supplies Project. Project No. 641-0109.
  373. Ministerial Instruction No. 779 of 3 March 1988 relating to promotion of a Maternal-Child Health Programme Including Family Planning (SMI/PF) in health establishments in Rwanda, 3 March 1988.
  374. Ministerial Resolution of 10 February 1989 creating the Permanent Inter-institutional Commission of the National Family Planning Programme.
  375. Mobilizing the resources of the for-profit sector to support the expansion of family planning services in the developing world.
  376. A model for planning local contraceptive services.
  377. Modelling the inverse association between breastfeeding and contraceptive use.
  378. Modern contraception is little known, rarely used in Ondo State, Nigeria.
  379. Modern contraceptive use as a determinant of fertility in Africa.
  380. Modernization and religiosity of health and family planning personnel; its influence on Upazila family planning performance in Bangladesh.
  381. Morrhuic acid vaginal contraceptive suppository.
  382. Motion pictures and commercial television: a co-production of public and private sectors to promote family planning in Mexico. [Cine y television comercial: una coproduccion de los sectores publico y privado para promover la planificacion familiar en Mexico.]
  383. Motivation for contraception use in Egypt.
  384. The multifaceted impact of religiosity on adolescent sexual experience and contraceptive usage: a reply to Shornack and Ahmed.
  385. Multinomial logit analysis of contraceptive method choice.
  386. Myriad voices in the contraceptive debates.

     

  387. The national family planning programme: plan of operations 1989-1993.
  388. National Indonesia Contraceptive Prevalence Survey, 1987.
  389. National Seminar on Consideration of the Family Planning IEC Strategy in Morocco, Mohammedia, June 23-25, 1989. Final report. [Seminaire National de Reflexion sur la Strategie d'IEC en Matiere de P.F. au Maroc (Mohammedia, du 23 au 25 Juin 1989). Rapport final.]
  390. National survey of Family Planning, Fertility and Health of the Population of Morocco 1987, summary report. [Enquete Nationale sur la Planification Familiale, la Fecondite et la Sante de la Population au Maroc 1987, rapport de synthese.]
  391. National Survey on Family Planning, Fertility and Health of the Population of Morocco (ENPS) 1987. [Enquete Nationale sur la Planification Familiale, la Fecondite et la Sante de la Population au Maroc (ENPS) 1987.]
  392. National Survey on Maternal and Infant Health and Family Planning 1986, final summary. [Pesquisa Nacional Sobre Saude Materno-Infantil e Planejamento Familiar 1986, relatorio resumido.]
  393. Natural family planning and the new technologies.
  394. Natural family planning: a good option.
  395. Natural methods and birth control: a choice in harmony with the conjugal anthropology of the couple.
  396. The nature of family planning management in China.
  397. Nausea, vomiting and the efficacy of post-coital contraception [letter]
  398. Nausea, vomiting and the efficacy of post-coital contraception. Reply [letter]
  399. The need for reliable contraception.
  400. New contraceptive methods and reproductive health.
  401. New male contraceptive entering clinical trials worldwide.
  402. New progestogens in oral contraceptives. [Neue Gestagene in oralen hormonalen Kontrazeptiva.]
  403. A new test system for evaluating the risk of thromboembolism in the use of hormonal contraceptives. [Ein neues Testsystem zur Bewertung des Thromboembolierisikos bei Einnahme hormonaler Kontrazeptiva.]
  404. Niger: family planning makes a dent. A post-project evaluation of knowledge, attitudes and practices related to family planning, Niamey, Maradi and Zinder, Niger. [Niger: la planification familiale fait une percee. Une evaluation d'apres-projet sur les connaissances, les attitudes et les pratiques liees a la planification familiale, Niamey, Maradi et Zinder, Niger.]
  405. Ninth semi-annual report, 15 September 1988 - 14 March 1989, INOPAL Project. Operations Research to Improve Family Planning and Maternal-Child Health Service Delivery Systems in Latin America and the Caribbean (DPE-3030-C-00-4074-00). Summary.
  406. Non-governmental organizations: their roles in family planning program in Nepal.
  407. Noncontraceptive health benefits and risks of steroidal contraception.
  408. Nonhormonal mediation of male reproductive tract damage: data from contraceptive drug research.
  409. Nonmenstrual toxic shock syndrome associated with barrier contraceptives: report of a case-control study.
  410. Norplant, contraceptive subdermal implants: introduction progress summary.
  411. North America at the hour of the third contraceptive revolution: the spectacular rise of sterilization to the first position among methods used. [L'Amerique du Nord a l'heure de la troisieme revolution contraceptive: la montee spectaculaire de la sterilisation au premier rang des methodes utilisees.]
  412. The number of children, use of oral contraceptives and menopausal status in relation to the number of remaining teeth and the periodontal bone height. A population study of women in Gothenburg, Sweden.
  413. Old and new ways: family planning in Kenya.
  414. On family planning in the year 2000. [O planeamento familiar no ano 2000.]
  415. On the effects of socio-economic development and family planning on the decline of fertility in China.
  416. On the relative bioavailability of the triphasic contraceptive Trisiston using levonorgestrel as an example. [Zur relevanten bioverfugbarkeit des triphasischen Kontrazeptivums Trisiston am Beispiel des Levonorgestrel.]
  417. On the woman as subject in family planning. [A mulher como sujeito no planejamento familiar.]
  418. Operations research on rural family planning programs. [Investigacion operativa sobre programas rurales de planificacion familiar.]
  419. The ophthalmologic effects of oral contraceptives.
  420. Opinion survey on the bioethical views of Catholic physicians in Japan. I. Contraception and induced abortion.
  421. Optimal birth control of population dynamics.
  422. Oral contraception and genital tract malignancy [letter]
  423. Oral contraception and genital-tract malignancy [letter]
  424. Oral contraception and genital-tract malignancy [letter]
  425. Oral contraception and genital-tract malignancy [letter]
  426. Oral contraception and post-operative thromboembolism: an epidemiological review.
  427. Oral contraception and surgery. [Contraception orale et chirurgie.]
  428. Oral contraception and the vascular risk. [Contracepcao oral e risco vascular.]
  429. Oral contraception with low-dose progestagen. [Orale Kontrazeption mit niedrig dosiertem Progestagen.]
  430. Oral contraceptive pills and prolactin.
  431. Oral contraceptive steroids and breast secretions.
  432. Oral contraceptive treatment for rheumatoid arthritis: an open study in 10 female patients.
  433. Oral contraceptive use and the risk of cancer. [Contraceptifs oraux et risque de cancer.]
  434. Oral contraceptive use and the risk of chlamydial and gonococcal infections.
  435. Oral contraceptive use in women with chronic medical conditions.
  436. Oral contraceptive use influences resting breast proliferation.
  437. Oral contraceptive use linked to chlamydial, gonococcal infections.
  438. Oral contraceptive use.
  439. Oral contraceptives and blood diseases are the most common causes of Budd-Chiari syndrome. [P-piller och blodsjukdomar vanligaste orsakerna till Budd-Chiaris syndrom.]
  440. Oral contraceptives and breast cancer [letter]
  441. Oral contraceptives and breast cancer [letter]
  442. Oral contraceptives and breast cancer [letter]
  443. Oral contraceptives and breast cancer [letter]
  444. Oral contraceptives and breast cancer [letter]
  445. Oral contraceptives and breast cancer.
  446. Oral contraceptives and breast cancer.
  447. Oral contraceptives and breast cancer: is the CASH study really negative? [letter]
  448. Oral contraceptives and breast cancer: latest findings in a large cohort study.
  449. Oral contraceptives and cancer. [Die Pille und Krebs.]
  450. Oral contraceptives and diabetes mellitus.
  451. Oral contraceptives and intestinal ischaemia [letter]
  452. Oral contraceptives and lipids.
  453. Oral contraceptives and malignancies of genital tract [letter]
  454. Oral contraceptives and neoplasia: 1989 update.
  455. Oral contraceptives and primary liver cancer.
  456. Oral contraceptives and stroke [letter]
  457. Oral contraceptives and stroke. [Reply] [letter]
  458. Oral contraceptives and the risk of rheumatoid arthritis: a meta-analysis of a conflicting literature.
  459. Oral contraceptives, breast cancer, and lactation [letter]
  460. Oral contraceptives, lipid and lipoprotein changes, and risk of coronary heart disease.
  461. Oral contraceptives, tobacco smoking, and breast cancer risk.
  462. Oral contraceptives: a reassessment.
  463. Planned Parenthood of Southern Nevada, Inc. v. Clark County School District [11 October 1989]
  464. Planning the family: community nurse profile.
  465. Plasma levonorgestrel levels and ovarian function during the use of a levonorgestrel-releasing intracervical contraceptive device.
  466. Policy aspects of community participation in maternal and child health and family planning programmes.
  467. Policy implications and future program issues of family planning and fertility reduction in Jordan.
  468. Policy on foreign aid for family planning debated.
  469. Polymorphic light eruption induced by oral contraceptives and pregnancy?
  470. Population and family planning strategy. Draft.
  471. Population growth and the need to implement family planning programs. [Crecimiento poblacional y la necesidad de implementar programas de planificacion familiar.]
  472. Population policy, fertility and family planning in Iran.
  473. Population trends. On contraceptive prevalence in Sao Paulo State. [Tendencias populacionais. A prevalencia de metodos anticoncepcionais no estado de Sao Paulo.]
  474. Population: oral contraceptives and breast cancer [memorandum]
  475. Population: recommendation for approval of Norplant subdermal contraceptive implants [memorandum]
  476. The position of gynecologists on planned parenthood and contraception. [Postoje gynekologu k planovanemu rodicovstvi a antikoncepci.]
  477. A possible clinical correlation between oral contraception and folic anemia in pregnancy. [Possibile correlazione clinica tra contraccezione orale ed anemia folica in gravidanza.]
  478. Possible interactions between antibiotics and oral contraceptives.
  479. Post-KAP and evaluation study on the family planning program at Lever Brothers Nigeria Limited and UAC Nigeria Limited.
  480. Postcoital contraception: a necessary, important option.
  481. Postpartum IUD contraception -- a review of an international experience.
  482. The potential contribution of family planning programs in slowing the spread of AIDS in Sub-Saharan Africa.
  483. Power in college students' contraceptive decisions.
  484. Practical prescribing of the combined oral contraceptive pill.
  485. Preconceptional family health evaluation: bringing clinical genetics education to New England family planning patients.
  486. Predicting contraceptive efficacy: a discriminant analysis of three groups of adolescent women.
  487. Predicting contraceptive use in Bangladesh: a logistic regression analysis.
  488. Pregnancy, contraception, and family planning services in industrialized countries.
  489. Preliminary investigation of the impact of sustainability policies on access to voluntary surgical contraception services.
  490. The prevalence of abnormal cervical cytology in a group of New Zealand women using contraception: a preliminary report.
  491. Prevalence of contraceptive use and fertility.
  492. Prevalence of use and effect of family planning programs. [Prevalencia de uso y efecto de los programas de planificacion familiar.]
  493. Preventing what? Contraceptives key to pregnancy prevention.
  494. Prevention of AIDS at sites of community distribution (DCC) of contraceptives in Kinshasa. [La prevention du SIDA dans les sites DCC de Kinshasa.]
  495. Private sector joins family planning effort.
  496. Pro-quality life. A Catholic layman explains: "Why I cannot agree with my church's stand against artificial contraception".
  497. Process of creation of pamphlets: a case of production of five pamphlets on contraception. [Proceso de elaboracion de folletos: un caso de produccion de cinco folletos sobre anticoncepcion.]
  498. Profile of patients attending the family planning service (CO.PLA.FA, San Justo, Pcia. de Santa Fe) in the first six months. [Perfil de las pacientes atendidas en los primeros seis meses del consultorio de planificacion familiar. (CO.PLA.FA. - San Justo - Pcia. de Santa Fe)]
  499. Program to motivate post-partum women to use family planning methods. [Programme de motivation des femmes en post-partum a l'utilisation des methodes de planification familiale.]
  500. Programmatic alignments of the IEC subsystem of the National Family Planning Program. [Lineamientos programaticos del sub-sistema de I.E.C. del Programa Nacional de Planificacion Familiar.]

To view other lists of the current category of articles, please visit "Category Lists Homepage"


Web PubHealth.info

© Copyrights PubHealth.info®, an information portal on public health. All rights reserved.

This page is optimized to be viewed by Java script enabled Microsoft® Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels.